← Leaderboards
John Barranger
University Of Pittsburgh At Pittsburgh
$6,068
Attributed
$6,068
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$6,068 · 2
By mechanism
M01$6,068 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- John A Barranger$2,026,465
- M. Ilyas Kamboh$33,365,358
- Susan R Sesack$4,604,811
- Mary L Marazita$48,708,804
- Vishwajit Laxmikant Nimgaonkar$23,658,670
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationGaucher'S DiseaseClinical ResearchGene ExpressionGene TherapyGenetic TransductionGlucosylceramidaseHematopoietic Stem CellsHematopoietic Tissue TransplantationHuman Genetic Material TagInjection /InfusionSynthetic EnzymeClinical TrialsEnzyme ActivityEnzyme Therapy
Grant awards (8)
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASES INFUSIONS$0
M01 · FY2002 · RR
CLINICAL TRIAL OF GENE THERAPY OF GAUCHER DISEASE$0
M01 · FY2002 · RR
CLINICAL TRIAL OF GENE THERAPY OF GAUCHER DISEASE$0
M01 · FY2002 · RR
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASES INFUSIONS$0
M01 · FY2002 · RR
CLINICAL TRIAL OF GENE THERAPY OF GAUCHER DISEASE$0
M01 · FY2001 · RR
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASES INFUSIONS$0
M01 · FY2001 · RR
CLINICAL TRIAL OF GENE THERAPY OF GAUCHER DISEASE$3,034
M01 · FY2000 · RR
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASES INFUSIONS$3,034
M01 · FY2000 · RR